(WWSB) - 35 years ago, a pair of scientists made a discovery that they believed would change Alzheimer’s research forever.

In the past two years, the U.S. Food and Drug Administration has approved two monoclonal antibody treatments to slow ...

Two new drugs, the first capable of slowing down the debilitating progression of Alzheimer's disease, have become embroiled ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

The FDA has approved a groundbreaking new drug to slow the progression of Alzheimer's disease in its early stages, offering ...

Leqembi and Kisunla don’t just reduce amyloid plaques that are implicated in Alzheimer’s disease. According to new research, ...

Much of the brain is made up of a constellation of star-shaped cells called astrocytes, which play vital roles in immunity, ...

This year's World Alzheimer's Day campaign aims to address the stigma and discrimination while highlighting global efforts to ...

Researchers have discovered that Alzheimer's drugs Leqembi and Kisunla boost levels of a healthy form of protein in the brain, even as they reduce its more toxic form.

Researches have helped in detecting the disease in early stages and drugs are now being made available for an effective and ...

Data from the federal government shows that Mississippi consistently ranks in the top five in the nation for its rates of ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...